The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.

by Mingfei Li, Ying Wang, Ndindam Ndiwane, Michelle B Orner, Natalia Palacios, Brant Mittler, Dan Berlowitz, Lewis E Kazis, Weiming Xia
Published 2021-01-01